MARKET

LLY

LLY

Lilly Eli & Co
NYSE
1,058.18
+37.34
+3.66%
After Hours: 1068.53 +10.35 +0.98% 19:59 02/06 EST
OPEN
1,056.00
PREV CLOSE
1,020.84
HIGH
1,060.02
LOW
1,033.27
VOLUME
4.89M
TURNOVER
--
52 WEEK HIGH
1,133.95
52 WEEK LOW
621.50
MARKET CAP
1.00T
P/E (TTM)
46.11
1D
5D
1M
3M
1Y
5Y
1D
FDA Crackdown on Compounded GLP-1s Strengthens Eli Lilly’s Obesity and Diabetes Franchise, Supporting Buy Rating
TipRanks · 2h ago
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Canopy Growth (CGC)
TipRanks · 2h ago
Eli Lilly Shares Surge on Weight-Loss Drug Momentum. Is It Time to Buy the Stock?
The Motley Fool · 3h ago
Is Eli Lilly (LLY) Still Attractive After Strong Multi‑Year Share Price Gains?
Simply Wall St · 3h ago
Eli Lilly expands partnership with Innovent to develop oncology, immunology drugs
Seeking Alpha · 4h ago
Hims & Hers ($HIMS) Shares Sink 16% as FDA Crackdown Halts Wegovy Copycat Pill
TipRanks · 10h ago
The Week That Was, The Week Ahead: Macro and Markets, Feb. 8
TipRanks · 10h ago
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
The Motley Fool · 16h ago
More
About LLY
Eli Lilly and Company is a medicine company, which discovers, develops, manufactures, markets, and sells pharmaceutical products worldwide. Its cardiometabolic health products include Basaglar; Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, and others; Humulin, Humulin 70/30, and others; Jardiance; Mounjaro; Trulicity; Zepbound; VERVE-102; VERVE-201, and VERVE-301. Its oncology products include Cyramza, Erbitux, Tyvyt, and Verzenio. Its immunology products include Ebglyss, Olumiant, Omvoh, and Taltz. Its neuroscience products include Emgality and Kisunla. The Company is also engaged in radiopharmaceutical discovery, development, and manufacturing efforts, and clinical and pre-clinical radioligand therapies in development for the treatment of cancer. It is also developing an oral small molecule inhibitor of a4b7 integrin for inflammatory bowel disease (IBD). It is evaluating its novel gene therapy candidate, ixoberogene soroparvovec.

Webull offers Eli Lilly And Co stock information, including NYSE: LLY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LLY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LLY stock methods without spending real money on the virtual paper trading platform.